Activities of Pilar AYUSO related to 2012/2066(INI)
Plenary speeches (1)
Protection of public health from endocrine disrupters (debate)
Amendments (9)
Amendment 13 #
Motion for a resolution
Recital A
Recital A
A. whereas hormone-related disorders and illnesschanges in humans have increased over the last 20 years, including impaired sperm quality, early onset of puberty, increased inwhich fact has been connected with a broad spectrum of illnesses, and whereas scidence of deformed sexual organs, increased incidence of ctific research is needed to obtain a better understain forms of cancnding of these disorders and many cases of metabolic illnessestheir aetiology;
Amendment 23 #
Motion for a resolution
Recital D – indent 3
Recital D – indent 3
Amendment 27 #
Motion for a resolution
Recital D – indent 5 a (new)
Recital D – indent 5 a (new)
- many elements and substances can affect the endocrine system and studies and scientific tests on the interaction of some chemicals which might be endocrine disruptors need therefore to be carried out in sufficient number;
Amendment 77 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Considers that the criteria ought to help classify the substances in a hierarchy based on their potential for producing adverse effects;
Amendment 101 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls on the Commission, in its review of EU strategy on endocrine disruptors, to place greater emphasistake account onf the precautionary principle and to use a scientific risk assessment as its basis as it works towards reducing human exposure to endocrine disruptors;
Amendment 111 #
Motion for a resolution
Paragraph 10 a (new)
Paragraph 10 a (new)
10a. Believes that the precautionary and preventive action principle, required under Article 191(2) of the Treaty on the Functioning of the European Union in order to achieve a high level of protection, has to take account of the principle of scientific assessment of the risk and dangers involved.
Amendment 132 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses that endocrine disruptors should be regarded asspecial precautions will need to be taken for those substances for which it is not possible, using validated scientific methods, to set a limit value at which effects may occur (‘non- threshold’ substances) and that any exposure to such substancesand exposure to which may entail a risk;
Amendment 138 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Calls on the Commission to support targeted research projects on endocrine disruptorslements and substances likely to affect the endocrine system and to emphasise the adverse effects at low concentrations or through combined exposure, including the development of new testing and analysis methods;
Amendment 144 #
Motion for a resolution
Paragraph 15 a (new)
Paragraph 15 a (new)
15a. Calls on the Commission to require all products imported from third countries to comply with all present and future EU legislation on endocrine disruptors;